Agonistic or antagonistic action of Kampo medicines used for menopausal symptoms on estrogen receptor subtypes, ERα and ERβ

Journal of Traditional Medicines

Volumn 23, Issue 6, 2006, Pages 203-207

  Watanabe, Koji ^a   Hyuga, Sumiko ^a   Hyuga, Masashi ^b   Kawanishi, Toru ^b   Hanawa, Toshihiko ^a  

^a KITASATO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349174398     PISSN: 18801447     EISSN: 18813747     Source Type: Journal    
DOI: 10.11339/jtm.23.203     Document Type: Article

References (10)

1. Jacobs, P. A., Hyland, M. E.: An evaluation of the benefits of taking hormone replacement therapy with other prescription drugs. Maturitas, 46, 273-281, 2003.
2. Beral, V.: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 362, 419-427, 2003.
3. Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., Jackson, R. D., Beresford, S. A., Howard, B. V., Johnson, K. C., Kotchen, J. M., Ockene, J.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Jama, 288, 321-333, 2002.
4. Pan, B., Kato, Y., Sengoku, K., Takuma, N., Niizeki, N., Ishikawa, M.: Treatment of climacteric symptoms with herbal formulas of traditional Chinese medicine. Gynecol. Obstet. Invest., 57, 144-148, 2004.
5. Kumagai, Y., Hyuga, S., Hyuga, M., Watanabe, K., Kawanishi, T., Hanawa, T.: Estrogen-like activity in Kampo medicines used for menopausal symptoms and gynecological diseases. J. Trad. Med., 22, 228-236, 2005.
6. Wang, C. Y., Huang, H. Y., Kuo, K. L., Hsieh, Y. Z.: Analysis of Puerariae radix and its medicinal preparations by capillary electrophoresis. J. Chromatogr. A. 802, 225-231, 1998.
7. An, J., Tzagarakis-Foster, C., Scharschmidt, T. C., Lomri, N., Leitman, D. C.: Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J. Biol. Chem., 276, 17808-17814, 2001.
8. Bardin, A., Boulle, N., Lazennec, G., Vignon, F., Pujol, P.: Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr. Relat. Cancer., 11, 537-551, 2004.
9. Paruthiyil, S., Parmar, H., Kerekatte, V., Cunha, G. R., Firestone, G. L., Leitman, D. C.: Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer. Res., 64, 423-428, 2004.
10. Gao, J., Hattori, M.: Metabolic activation of lignans to estrogenic and anti-estrogenic substances by human intestinal bacteria. J. Trad. Med., 22, 213-221, 2005.